Bristol-Myers CMO: ‘This is the best time to be in drug development’

Bristol-Myers CMO: ‘This is the best time to be in drug development’

STAT Plus: Bristol-Myers CMO on cell therapies: ‘This is the best time to be in drug development’

By ADAM FEUERSTEIN

MEL EVANS/AP

Dr. Samit Hirawat of Bristol-Myers Squibb talks about Bristol’s commitment to CAR-T, the integration of Celgene, and saying no when data go bad.

READ MORE